13D Filings

ARCH Venture Fund X, L.P.

CIK

1757011

13D Filings

3

Companies

2

Latest Filing

Apr 1, 2026, 04:10 PM

Filing History
Company
% Owned
Type
Filed
Neumora Therapeutics, Inc.
NMRA

18.70%

-2.00%

Amendment

Apr 1, 2026, 04:10 PM

Neumora Therapeutics, Inc.
NMRA

20.70%

Amendment

Oct 29, 2025, 07:07 PM

Prime Medicine, Inc.
PRME

10.40%

Amendment

Aug 11, 2025, 09:48 PM

Rows:

13 of 3

1
ARCH Venture Fund X, L.P. — 13D Filings | 13D Filings